Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 06, 2010 |
referred to investigations and government operations |
Sep 03, 2009 |
print number 2745a |
Sep 03, 2009 |
amend and recommit to investigations and government operations |
Mar 02, 2009 |
referred to investigations and government operations |
Senate Bill S2745
2009-2010 Legislative Session
Sponsored By
(R, C, IP) Senate District
Archive: Last Bill Status - In Senate Committee Investigations And Government Operations Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
Bill Amendments
co-Sponsors
(R, C, IP) Senate District
2009-S2745 - Details
- Current Committee:
- Senate Investigations And Government Operations
- Law Section:
- Tax Law
- Laws Affected:
- Add §31, amd §§210 & 606, Tax L
2009-S2745 - Summary
Establishes a business franchise and personal income tax credit for the targeted human pharmacological project fee paid to the Food and Drug Administration for the purposes of submitting a human drug application or supplement when the research and development were primarily done in this state.
2009-S2745 - Sponsor Memo
BILL NUMBER: S2745 TITLE OF BILL : An act to amend the tax law, in relation to establishing a targeted human pharmacological project fee credit SUMMARY OF PROVISIONS : Section 1 amends the tax law by adding a new section 30, the targeted human pharmacological project fee credit which is a 50% credit against the costs of approval of a drug by the FDA. The credit is only available when the company begins manufacturing in New York. Section 2 makes the credit available against the corporation franchise tax Section 3 is a technical amendment, and Section 4 provides that the credit can be taken against income tax. JUSTIFICATION : This tax credit will help keep growth companies in New York, and should serve as a major spur to the growth of the biotechnology industry here. PRIOR LEGISLATIVE HISTORY : 2008 - Passed senate. FISCAL IMPLICATIONS : None in the 2008-9 fiscal year.
2009-S2745 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2745 2009-2010 Regular Sessions I N S E N A T E March 2, 2009 ___________ Introduced by Sen. GOLDEN -- read twice and ordered printed, and when printed to be committed to the Committee on Investigations and Govern- ment Operations AN ACT to amend the tax law, in relation to establishing a targeted human pharmacological project fee credit THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The tax law is amended by adding a new section 30 to read as follows: S 30. TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (A) DEFI- NITIONS. AS USED IN THIS SECTION THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (1) "PRIMARILY" SHALL MEAN MORE THAN FIFTY PERCENT. (2) "RESEARCH AND DEVELOPMENT COSTS" SHALL MEAN IN-HOUSE RESEARCH EXPENSES WITHIN THE MEANING OF SECTION 41 (B) (2) OF THE INTERNAL REVEN- UE CODE. (3) "PROJECT FEES" SHALL MEAN THE MONETARY AMOUNT ACTUALLY PAID TO THE U.S.F.D.A. THAT CONSTITUTES THE FEE DUE UPON THE SUBMISSION OF A HUMAN DRUG APPLICATION OR SUPPLEMENT PURSUANT TO U.S.C. S 379 H (A) (1) FOR A HUMAN DRUG, RESEARCH AND DEVELOPMENT COSTS OF WHICH WERE PRIMARILY INCURRED IN NEW YORK STATE. (4) "U.S.F.D.A." SHALL MEAN THE UNITED STATES FOOD AND DRUG ADMINIS- TRATION. (B) TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (1) A TAXPAYER WHO IS SUBJECT TO TAX UNDER ARTICLE NINE-A OR TWENTY-TWO OF THIS CHAPTER SHALL BE ALLOWED A CREDIT AGAINST SUCH TAX. SUCH CREDIT SHALL BE ALLOWED WITH RESPECT TO PROJECT FEES. (2) THE APPLICABLE PERCENTAGE SHALL EQUAL THIRTY-SIX PERCENT OF THE COST OF PROJECT FEES. (3) THE CREDIT ALLOWED UNDER THIS SECTION MAY ONLY BE CLAIMED AFTER ITS LICENSURE IS APPROVED BY THE U.S.F.D.A. AND THE TAXPAYER IS LICENSED EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD07650-01-9
co-Sponsors
(R, C, IP) Senate District
2009-S2745A (ACTIVE) - Details
- Current Committee:
- Senate Investigations And Government Operations
- Law Section:
- Tax Law
- Laws Affected:
- Add §31, amd §§210 & 606, Tax L
2009-S2745A (ACTIVE) - Summary
Establishes a business franchise and personal income tax credit for the targeted human pharmacological project fee paid to the Food and Drug Administration for the purposes of submitting a human drug application or supplement when the research and development were primarily done in this state.
2009-S2745A (ACTIVE) - Sponsor Memo
BILL NUMBER: S2745A TITLE OF BILL : An act to amend the tax law, in relation to establishing a targeted human pharmacological project fee credit SUMMARY OF PROVISIONS : Section 1 amends the tax law by adding a new section 31, the targeted human pharmacological project fee credit which is a full credit against the costs of approval of a drug by the FDA. The credit is only available when the company begins manufacturing in New York. Section 2 makes the credit available against the corporation franchise tax, Section 3 is a technical amendment, and Section 4 provide s that the credit can be taken against income tax. JUSTIFICATION : This tax credit will help keep growth companies in New York, and should serve as a major spur to the growth of the biotechnology industry here. PRIOR LEGISLATIVE HISTORY : 2008 - Passed Senate. FISCAL IMPLICATIONS : $10 million a year beginning in SFY 2011-12.
2009-S2745A (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 2745--A 2009-2010 Regular Sessions I N S E N A T E March 2, 2009 ___________ Introduced by Sens. GOLDEN, HANNON -- read twice and ordered printed, and when printed to be committed to the Committee on Investigations and Government Operations -- committee discharged, bill amended, ordered reprinted as amended and recommitted to said committee AN ACT to amend the tax law, in relation to establishing a targeted human pharmacological project fee credit THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. The tax law is amended by adding a new section 31 to read as follows: S 31. TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (A) DEFI- NITIONS. AS USED IN THIS SECTION THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: (1) "PRIMARILY" SHALL MEAN MORE THAN FIFTY PERCENT. (2) "RESEARCH AND DEVELOPMENT COSTS" SHALL MEAN IN-HOUSE RESEARCH EXPENSES WITHIN THE MEANING OF SECTION 41 (B) (2) OF THE INTERNAL REVEN- UE CODE. (3) "PROJECT FEES" SHALL MEAN THE MONETARY AMOUNT ACTUALLY PAID TO THE U.S.F.D.A. THAT CONSTITUTES THE FEE DUE UPON THE SUBMISSION OF A HUMAN DRUG APPLICATION OR SUPPLEMENT PURSUANT TO U.S.C. S 379 H (A) (1) FOR A HUMAN DRUG, RESEARCH AND DEVELOPMENT COSTS OF WHICH WERE PRIMARILY INCURRED IN NEW YORK STATE. (4) "U.S.F.D.A." SHALL MEAN THE UNITED STATES FOOD AND DRUG ADMINIS- TRATION. (B) TARGETED HUMAN PHARMACOLOGICAL PROJECT FEE CREDIT. (1) A TAXPAYER WHO IS SUBJECT TO TAX UNDER ARTICLE NINE-A OR TWENTY-TWO OF THIS CHAPTER SHALL BE ALLOWED A CREDIT AGAINST SUCH TAX. SUCH CREDIT SHALL BE ALLOWED WITH RESPECT TO PROJECT FEES. (2) THE APPLICABLE PERCENTAGE SHALL EQUAL THIRTY-SIX PERCENT OF THE COST OF PROJECT FEES. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD07650-02-9
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.